Fuad El-Hibri
2019
In 2019, Fuad El-Hibri earned a total compensation of $3M as Executive Chairman of the Board of Directors at Emergent BioSolutions, a 1% increase compared to previous year.
Compensation breakdown
| Option Awards | $773,813 |
|---|---|
| Salary | $1,131,577 |
| Stock Awards | $1,099,949 |
| Other | $4,723 |
| Total | $3,010,062 |
El-Hibri received $1.1M in salary, accounting for 38% of the total pay in 2019.
El-Hibri also received $773.8K in option awards, $1.1M in stock awards and $4.7K in other compensation.
Rankings
In 2019, Fuad El-Hibri's compensation ranked 4,078th out of 13,971 executives tracked by ExecPay. In other words, El-Hibri earned more than 70.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,078 out of 13,971 | 71st |
Division Manufacturing | 1,475 out of 5,701 | 74th |
Major group Chemicals And Allied Products | 518 out of 2,200 | 77th |
Industry group Drugs | 437 out of 1,886 | 77th |
Industry Pharmaceutical Preparations | 333 out of 1,398 | 76th |
Source: SEC filing on April 9, 2020.
El-Hibri's colleagues
We found six more compensation records of executives who worked with Fuad El-Hibri at Emergent BioSolutions in 2019.
2019
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2019
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2019
Richard Lindahl
Emergent BioSolutions
Chief Financial Officer
2019
Atul Saran
Emergent BioSolutions
General Counsel
2019
Adam Havey
Emergent BioSolutions
Executive Vice President, Business Operations
2019
Daniel Abdun-Nabi
Emergent BioSolutions